View in EDS

Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome.

Saved in:
Bibliographic Details
Title: Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome.
Authors: Zhang H; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Dang Y; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Guo Y; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China., Fisher D; Department of Medical Biosciences, Faculty of Natural Sciences, University of The Western Cape, Cape Town, South Africa., Hien NTT; Hai Phong University of Medicine and Pharmacy, Hai Phong, 04212, Viet Nam., Musabaev E; The Research Institute of Virology, Ministry of Health, Tashkent, 100122, Uzbekistan., Shmanai VV; Institute of Physical Organic Chemistry, National Academy of Sciences of Belarus, Surganova 13, Minsk, 220072, Belarus., Zhu Z; The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, 530023, China. Electronic address: 14650901@qq.com., Luo M; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China. Electronic address: lm20200108@163.com., Ge C; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China. Electronic address: chunxia_ge@126.com., Zhao L; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: leizhao@hust.edu.cn.
Source: European journal of pharmacology [Eur J Pharmacol] 2026 May 28; Vol. 1025, pp. 178928. Date of Electronic Publication: 2026 May 04.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42092484
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Zhang+H%22">Zhang H</searchLink>; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.<br /><searchLink fieldCode="AU" term="%22Dang+Y%22">Dang Y</searchLink>; Department of Vascular Surgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.<br /><searchLink fieldCode="AU" term="%22Guo+Y%22">Guo Y</searchLink>; Department of Neurology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.<br /><searchLink fieldCode="AU" term="%22Fisher+D%22">Fisher D</searchLink>; Department of Medical Biosciences, Faculty of Natural Sciences, University of The Western Cape, Cape Town, South Africa.<br /><searchLink fieldCode="AU" term="%22Hien+NTT%22">Hien NTT</searchLink>; Hai Phong University of Medicine and Pharmacy, Hai Phong, 04212, Viet Nam.<br /><searchLink fieldCode="AU" term="%22Musabaev+E%22">Musabaev E</searchLink>; The Research Institute of Virology, Ministry of Health, Tashkent, 100122, Uzbekistan.<br /><searchLink fieldCode="AU" term="%22Shmanai+VV%22">Shmanai VV</searchLink>; Institute of Physical Organic Chemistry, National Academy of Sciences of Belarus, Surganova 13, Minsk, 220072, Belarus.<br /><searchLink fieldCode="AU" term="%22Zhu+Z%22">Zhu Z</searchLink>; The First Clinical Medical College, Guangxi University of Chinese Medicine, Nanning, 530023, China. Electronic address: 14650901@qq.com.<br /><searchLink fieldCode="AU" term="%22Luo+M%22">Luo M</searchLink>; Department of Infectious Diseases, Henan Provincial People's Hospital, Zhengzhou University People's Hospital, Zhengzhou, China. Electronic address: lm20200108@163.com.<br /><searchLink fieldCode="AU" term="%22Ge+C%22">Ge C</searchLink>; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China. Electronic address: chunxia_ge@126.com.<br /><searchLink fieldCode="AU" term="%22Zhao+L%22">Zhao L</searchLink>; The Second School of Clinical Medicine of Binzhou Medical University, Yantai, 264003, China; Department of Infectious Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Electronic address: leizhao@hust.edu.cn.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%221254354%22">European journal of pharmacology</searchLink> [Eur J Pharmacol] 2026 May 28; Vol. 1025, pp. 178928. <i>Date of Electronic Publication: </i>2026 May 04.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Elsevier+Science%22">Elsevier Science </searchLink><i>Country of Publication: </i>Netherlands <i>NLM ID: </i>1254354 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1879-0712 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200142999%22">00142999 </searchLink><i>NLM ISO Abbreviation: </i>Eur J Pharmacol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42092484
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.ejphar.2026.178928
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 178928
    Titles:
      – TitleFull: Dihydromyricetin: A potential candidate for the treatment of cholestatic liver injury via inhibition of the NLRP3 inflammasome.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Zhang H
      – PersonEntity:
          Name:
            NameFull: Dang Y
      – PersonEntity:
          Name:
            NameFull: Guo Y
      – PersonEntity:
          Name:
            NameFull: Fisher D
      – PersonEntity:
          Name:
            NameFull: Hien NTT
      – PersonEntity:
          Name:
            NameFull: Musabaev E
      – PersonEntity:
          Name:
            NameFull: Shmanai VV
      – PersonEntity:
          Name:
            NameFull: Zhu Z
      – PersonEntity:
          Name:
            NameFull: Luo M
      – PersonEntity:
          Name:
            NameFull: Ge C
      – PersonEntity:
          Name:
            NameFull: Zhao L
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 28
              M: 05
              Text: 2026 May 28
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1879-0712
          Numbering:
            – Type: volume
              Value: 1025
          Titles:
            – TitleFull: European journal of pharmacology
              Type: main
ResultId 1